In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Innovation

Set Alert for Innovation

How Debiopharm’s Licensing Model Bridges The Biotech And Pharma Gap

Sandra von Meier, head of business development and licensing at Debiopharm explains how the company’s distinctive licensing business model is helping bring new drugs to market.

BioPharmaceutical Cancer

Gene Therapy’s Next Target: Our Microbes

CRISPR pioneer Jennifer Doudna recently co-launched an initiative focused on microbial gene editing, but French biotech Eligo has been diligently working on this for 10 years. 

Innovation Gene Therapy

ASCO Roundup: Looking For The Future Of Cancer Research

As the American Society of Clinical Oncology annual meeting drew to a close, industry execs discussed staying competitive, adjusting to policy changes and how artificial intelligence is advancing cancer R&D.

ASCO Artificial Intelligence

Orphan Drugs – Slowdown Signals New Paths Ahead

Signs are that the rate of sales growth for orphan drugs is slowing but that does not mean that they have had their day. Far from it, finds a new report from Evaluate.

Innovation Commercial

Therapeutic Endoscopy: ‘We’re At The Start Of What’s Possible’

In the emerging field of therapeutic endoscopy, Creo Medical’s Speedboat devices are advancing minimally invasive treatment by combining advanced bipolar radiofrequency and super high frequency microwave energy in a single device, says CTO and founder Chris Hancock.

Innovation Cancer

Once Destined For Pro Rodeo, Women’s Health CEO Rides A Different Horse

2024 In Vivo Rising Leader Somer Baburek wants to overhaul how endometriosis is diagnosed and managed with a product that she says has billion-dollar potential.

Rising Leaders Women's Health

Will AI Obviate The Need For Animal Trials?

Quris-AI has built a platform that can simulate genetically diverse clinical trials on a chip. The technology may reduce biopharma’s need for animal testing and de-risk human testing. 

Innovation Artificial Intelligence

How Cellino’s Cassette Technology Will Impact Regenerative Medicine

Co-founder and CEO of Cellino Biotech, Nabiha Saklayen, discusses the company’s innovative platform which uses automated technologies to overcome challenges in the development of regenerative medicine.

Rising Leaders Regenerative Medicine

Closed Loop Medicine: Pairing Software With Drugs To Optimize Dosing

In this episode of the In Vivo podcast, Hakim Yadi, CEO and co-founder of UK techbio Closed Loop Medicine, discusses how the company is pairing software and predictive analytics with medications old and new to tailor drug dosing.  

Innovation Personalized Medicine

Isomorphic Boasts Its Latest AI Tool

AlphaFold 3 is promising, but for now it stays in the hands of Isomorphic Labs and its partners.

Artificial Intelligence Innovation

AMR, UTI, Breathomics And 3D Printing Technology Innovators Profiled At BioWales 2024

Breathomics, UTI diagnosis and advanced wound healing innovations were among the center stage technologies at BioWales in London 2024.

United Kingdom Innovation

Apogee CMO On New Approach To I&I Market

Having raised $345m in an IPO last year, prior to entering the clinic, Apogee Therapeutics has emerged as a startup to watch. Chief medical officer Carl Dambkowski, one of In Vivo’s 2024 Rising Leaders, shares more about the biotech’s pipeline strategy.

Inflammation Rising Leaders

How To Grow A Biotech - Insights From Scientist-Entrepreneurs

Laura Soucek, a former In Vivo Rising Leader, and her co-founder have built their biotech, Peptomyc, around a previously undruggable target. They spoke about successes and learnings as scientist-entrepreneurs at BioEurope Spring.

Innovation Rising Leaders

Vividion’s Breakthrough Science Is Fueling Bayer’s Pipeline

Leveraging the biotech entrepreneurial spirit and global pharma resources is a win-win situation in the race to bring meaningful medicines to patients.

Rising Leaders Oncology

Synthetic Biology Matures, Promising Affordable And Personalized Treatments

Advances in synthetic biology are moving biopharma closer to a world where treatments can be tailored while remaining cost-effective.

Innovation Artificial Intelligence

Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics

CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.

Rising Leaders Clinical Trials
See All
UsernamePublicRestriction

Register